Both of these processes are therefore accelerated towards degeneration in disease processes wherein S100B is increased, notably, Alzheimer's disease (AD) and Down syndrome (DS).In order to study the role of S100B in this context, we have examined S100B overexpressing transgenic mice. This evidence concerns the gene S100B and early-onset autosomal dominant Alzheimer disease.